Pfizer and BioNTech announced this week that their coronavirus vaccine is safe and highly effective in children ages 5 to 11, and soon they plan to seek authorization for this age group from the Food and Drug Administration.

The vaccine already is available for anyone 12 and older. For elementary school-aged kids, Pfizer tested a much lower dose — a third of the amount that’s in each shot given now. Yet after their second dose, children ages 5 to 11 developed coronavirus-fighting antibody levels just as strong as teenagers and young adults getting the regular-strength shots, Dr. Bill Gruber, a Pfizer senior vice president, told The Associated Press.

The Day would like to hear from parents in southeastern Connecticut who have kids in this age group, about whether they will have their kids vaccinated, and why or why not.

If you want to share your thoughts, fill out the form below or email Day Staff Writer Erica Moser at e.moser@theday.com.